EXELON Patch 15 patch mat 13.3 mg/24h 60 pce
7680580780061
CH-58078
N06DA03
01.99.0.
Reimbursement limitations:
THERAPIEBEG
En début de thérapie, application par ex. d'un test minimental.
Première évaluation intermédiaire après trois …
1 / 3
google
Details
- Product number
- 5807805
- CPT
- -
- Packaging group
- 60
- Unit
- Pflaster
- Composition
- rivastigminum 27 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, Trägermaterial: poly(ethylenis terephthalas), Drucktinte (Beige): ad praeparationem pro 15 cm², cum liberatione 13.3 mg/24h.
Articles (1)
Exelon Patch 15, transdermales Pflaster
Transdermales Pflaster
60
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
27.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | ANTOX |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 130.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2013
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 58078
- Drug name
- Exelon Patch, transdermales Pflaster
- Galenic form
- TRAP
- ATC Code
- N06DA03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 20/12/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EXELON Patch 15 patch mat 13.3 mg/24h 60 pce
- Description (DE)
- EXELON Patch 15 Matrixpfl 13.3 mg/24h 60 Stk
- Market launch
- 22/05/2013
- Narcotic (BTM)
- No